So! We are starting to see more positive news from NVAX -- Singapore. Philippines, etc.; stockholder enthusiasm regarding upcoming EU approval (hopefully), etc. PFE says their treatment pill may not be as good as first reported by them (and upon which their initial positive press release cratered NVAX). Now today a NVAX press release that maybe there might be something positive from NVAX in next couple of weeks regarding the newest/latest variant.
It has been difficult and dismaying holding NVAX during 2021: It is just so volatile, diving on competitor news, clawing back, dropping again on further positive reports from competitors already shipping or close to shipping billions of doses, or falling the news of new entrants planning to come into the covid vaccine business. What's made it so difficult for me is that I hold more than a full position in NVAX, so the volatility really shows in, and affects, my portfolios. Not helping my anxiety is that I am in the red with holdings in some portfolios (ex. taxable account).
Anyway, I'm looking to the next month to bring more approvals, and maybe to start to finally see NVAX vaccine being shipped. |
